Gryphon Financial Partners »

United Therapeutics Corporation shares owned by Gryphon Financial Partners

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Gryphon Financial Partners from 13F filings

Historical chart of Gryphon Financial Partners investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Gryphon Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Gryphon Financial Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $210k 586 358.35
2019-06-30 $2.0k 32 62.50

More positions owned by Gryphon Financial Partners

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Call (Principal) (SPY)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Dycom Industries (DY)
Microsoft Corporation (MSFT)
Abbvie (ABBV)
Meta Platforms Cl A (META)
Ishares Tr Msci Acwi Etf (ACWI)
NVIDIA Corporation (NVDA)
Abbott Laboratories (ABT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Procter & Gamble Company (PG)
Shopify Cl A (SHOP)
Amazon (AMZN)

View all positions for Gryphon Financial Partners

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation